SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 53 filers reported holding SPERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ROYAL BANK OF CANADA | 300 | $0 | 0.00% |
| Allworth Financial LP | 600 | $726 | 0.00% |
| VANGUARD GROUP INC | 1,557,596 | $1,884,691 | 0.00% |
| Heritage Wealth Advisors | 187 | $226 | 0.00% |
| UBS Group AG | 27,135 | $32,833 | 0.00% |
| RHUMBLINE ADVISERS | 458 | $554 | 0.00% |
| NewEdge Advisors, LLC | 100 | $121 | 0.00% |
| PRUDENTIAL FINANCIAL INC | 28,200 | $34,122 | 0.00% |
| Squarepoint Ops LLC | 129,497 | $156,691 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 12 | $15 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 17,023 | $20,598 | 0.00% |
| OSAIC HOLDINGS, INC. | 97 | $117 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,753 | $14,221 | 0.00% |
External links
This page lists SPERO THERAPEUTICS INC's shareholders in Q3 2023. To view SPERO THERAPEUTICS INC's shareholder history, click here.